A newly developed “GPS nanoparticle” injected intravenously can home in on cancer cells to deliver a genetic punch to the protein implicated in tumor growth and spread, according to researchers from Penn State.
Trailing Novartis and Eli Lilly, radiopharmaceuticals startup Full-Life Technologies nabs $63M to test new PSMA drug
As the US radiopharmaceutical space heats up with the acquisitions of RayzeBio and Point Biopharma, a younger startup based out of China and Belgium has